Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, J. Maller, P. Sklar, P.I. Bakker, M.J. Daly (2007)
PLINK: a tool set for whole-genome association and population-based linkage analyses, 81
Darst (2021)
616J. Natl. Cancer Inst., 113
S. Yepes, N.N. Shah, J. Bai, H. Koka, C. Li, S. Gui, M.L. McMaster, Y. Xiao, K. Jones, M. Wang (2021)
Rare germline variants in chordoma-related genes and chordoma susceptibility, 13
Wang (2014)
736Nat. Genet., 46
Landi (2009)
679Am. J. Hum. Genet., 85
Liu (2018)
1483J. Thorac. Oncol., 13
Locke (2019)
323Nature, 572
Bolger (2014)
2114Bioinformatics, 30
J. Shi, X.R. Yang, B. Ballew, M. Rotunno, D. Calista, M.C. Fargnoli, P. Ghiorzo, B. Bressac-de Paillerets, E. Nagore, M.F. Avril (2014)
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma, 46
Landi (2008)
203BMC Public Health, 8
K. Wang, M. Li, H. Hakonarson (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, 38
Karlsson (2021)
570Eur. Urol. Oncol., 4
Yepes (2021)
2704Cancers (Basel), 13
Yokoyama (2011)
1115Cancer Sci., 102
M.M. Aynaud, R. Suspene, P.O. Vidalain, B. Mussil, D. Guetard, F. Tangy, S. Wain-Hobson, J.P. Vartanian (2012)
Human tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A, 287
J. Gudmundsson, P. Sulem, T. Rafnar, J.T. Bergthorsson, A. Manolescu, D. Gudbjartsson, B.A. Agnarsson, A. Sigurdsson, K.R. Benediktsdottir, T. Blondal (2008)
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer, 40
Yonekawa (2011)
12746P. Natl. Acad. Sci. USA, 108
S. Yepes, M.A. Tucker, H. Koka, Y. Xiao, K. Jones, A. Vogt, L. Burdette, W. Luo, B. Zhu, A. Hutchinson (2020)
Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility, 10
Catalano (2021)
33Blood Cancer J., 11
A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly (2010)
The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, 20
Koch (2020)
448Nat. Rev. Genet., 21
Kramer (2014)
523Bioinformatics, 30
Y.H. Liu, C.M. Lusk, M.H. Cho, E.K. Silverman, D.D. Qiao, R.Y. Zhang, M.E. Scheurer, F. Kheradmand, D.A. Wheeler, S. Tsavachidis (2018)
Rare variants in known susceptibility loci and their contribution to risk of lung cancer, 13
Selvan (2019)
1517Clin. Cancer Res., 25
Naslavsky (2005)
4093J. Cell Sci., 118
L. Koch (2020)
Exploring human genomic diversity with gnomAD, 21
Siegel (2021)
7CA Cancer J. Clin., 71
C. Catalano, N. Paramasivam, J. Blocka, S. Giangiobbe, S. Huhn, M. Schlesner, N. Weinhold, R. Sijmons, M. Jong, C. Langer (2021)
Characterization of rare germline variants in familial multiple myeloma, 11
Cingolani (2012)
80Fly (Austin), 6
McKenna (2010)
1297Genome Res., 20
A. Kramer, J. Green, J. Pollard, S. Tugendreich (2014)
Causal analysis approaches in ingenuity pathway analysis, 30
A.M. Goldstein, Y. Xiao, J. Sampson, B. Zhu, M. Rotunno, H. Bennett, Y. Wen, K. Jones, A. Vogt, L. Burdette (2017)
Rare germline variants in known melanoma susceptibility genes in familial melanoma, 26
Q. Karlsson, M.N. Brook, T. Dadaev, S. Wakerell, E.J. Saunders, K. Muir, D.E. Neal, G.G. Giles, R.J. MacInnis, S.N. Thibodeau (2021)
Rare germline variants in ATM predispose to prostate cancer: a PRACTICAL Consortium Study, 4
S. Yonekawa, A. Furuno, T. Baba, Y. Fujiki, Y. Ogasawara, A. Yamamoto, M. Tagaya, K. Tani (2011)
Sec16B is involved in the endoplasmic reticulum export of the peroxisomal membrane biogenesis factor peroxin 16 (Pex16) in mammalian cells, 108
Y. Liu, F. Kheradmand, C.F. Davis, M.E. Scheurer, D. Wheeler, S. Tsavachidis, G. Armstrong, C. Simpson, D. Mandal, E. Kupert (2016)
Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer, 11
Purcell (2007)
559Am. J. Hum. Genet., 81
Q. Wang, R.S. Dhindsa, K. Carss, A.R. Harper, A. Nag, I. Tachmazidou, D. Vitsios, S.V.V. Deevi, A. Mackay, D. Muthas (2021)
Rare variant contribution to human disease in 281,104 UK Biobank exomes, 597
Wang (2021)
527Nature, 597
X.R. Yang, M. Rotunno, Y. Xiao, C. Ingvar, H. Helgadottir, L. Pastorino, R. Doorn, H. Bennett, C. Graham, J.N. Sampson (2016)
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations, 135
N. Naslavsky, S. Caplan (2005)
C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?, 118
Shi (2014)
482Nat. Genet., 46
J.D. McKay, R.J. Hung, Y. Han, X. Zong, R. Carreras-Torres, D.C. Christiani, N.E. Caporaso, M. Johansson, X. Xiao, Y. Li (2017)
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes, 49
D.N. Subramanian, M. Zethoven, S. McInerny, J.A. Morgan, S.M. Rowley, J.E.A. Lee, N. Li, K.L. Gorringe, P.A. James, I.G. Campbell (2020)
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes, 11
T. Yokoyama, T. Nakamura (2011)
Tribbles in disease: signaling pathways important for cellular function and neoplastic transformation, 102
Gudmundsson (2008)
281Nat. Genet., 40
Liu (2016)
52J. Thorac. Oncol., 11
Cingolani (2012)
35SnpSift. Front. Genet., 3
A.M. Bolger, M. Lohse, B. Usadel (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data, 30
A.E. Locke, K.M. Steinberg, C.W.K. Chiang, S.K. Service, A.S. Havulinna, L. Stell, M. Pirinen, H.J. Abel, C.C. Chiang, R.S Fulton (2019)
Exome sequencing of Finnish isolates enhances rare-variant association power, 572
Subramanian (2020)
1640Nat. Commun., 11
Lee (2012)
224Am. J. Hum. Genet., 91
Belinky (2015)
PathCards: multi-source consolidation of human biological pathwaysDatabase, 2015
S. Lee, M.J. Emond, M.J. Bamshad, K.C. Barnes, M.J. Rieder, D.A. Nickerson, N.G.E.S.P.-E.L.P. Team, D.C. Christiani, M.M. Wurfel, X. Lin (2012)
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies, 91
K. Tomczak, P. Czerwinska, M. Wiznerowicz (2015)
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge, 19
McKay (2017)
1126Nat. Genet., 49
P. Cingolani, A. Platts, L. Wang le, M. Coon, T. Nguyen, L. Wang, S.J. Land, X. Lu, D.M. Ruden (2012)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3, 6
N. Chatterjee, G.C. Walker (2017)
Mechanisms of DNA damage, repair, and mutagenesis, 58
Yang (2016)
1241Hum. Genet., 135
Chatterjee (2017)
235Environ. Mol. Mutagen., 58
T. Rafnar, G.R. Sigurjonsdottir, S.N. Stacey, G. Halldorsson, P. Sulem, L.M. Pardo, H. Helgason, S.T. Sigurdsson, T. Gudjonsson, L. Tryggvadottir (2018)
Association of BRCA2 K3326*with small cell lung cancer and squamous cell cancer of the skin, 110
P. Cingolani, V.M. Patel, M. Coon, T. Nguyen, S.J. Land, D.M. Ruden, X. Lu (2012)
Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, 3
Tomczak (2015)
A68Contemp. Oncol. (Pozn), 19
Liu (2021)
12Npj Precis. Oncol., 5
M.T. Landi, D. Consonni, M. Rotunno, A.W. Bergen, A.M. Goldstein, J.H. Lubin, L. Goldin, M. Alavanja, G. Morgan, A.F. Subar (2008)
Environment and genetics in lung cancer etiology (EAGLE) study: an integrative population-based case-control study of lung cancer, 8
R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal (2021)
Cancer statistics, 2021, 71
M.T. Landi, N. Chatterjee, K. Yu, L.R. Goldin, A.M. Goldstein, M. Rotunno, L. Mirabello, K. Jacobs, W. Wheeler, M. Yeager (2009)
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma, 85
Rafnar (2018)
967J. Natl. Cancer Inst., 110
Yepes (2020)
17198Sci. Rep., 10
B.F. Darst, T. Dadaev, E. Saunders, X. Sheng, P. Wan, L. Pooler, L.Y. Xia, S. Chanock, S.I. Berndt, S.M. Gapstur (2021)
Germline sequencing DNA repair genes in 5545 men with aggressive and nonaggressive prostate cancer, 113
F. Islami, A. Goding Sauer, K.D. Miller, R.L. Siegel, S.A. Fedewa, E.J. Jacobs, M.L. McCullough, A.V. Patel, J. Ma, I. Soerjomataram (2018)
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 68
Y.F. Wang, J.D. Mckay, T. Rafnar, Z.M. Wang, M.N. Timofeeva, P. Broderick, X.C. Zong, M. Laplana, Y.Y. Wei, Y.H. Han (2014)
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer, 46
M.E. Selvan, M.G. Zauderer, C.M. Rudin, S. Jones, S. Mukherjee, K. Offit, K. Onel, G. Rennert, V.E. Velculescu, S.M. Lipkin (2020)
Inherited rare, deleterious variants in atm increase lung adenocarcinoma risk, 15
Goldstein (2017)
4886Hum. Mol. Genet., 26
Selvan (2020)
1871J. Thorac. Oncol., 15
M.E. Selvan, R.J. Klein, Z.H. Gumus (2019)
Rare, pathogenic germline variants in Fanconi anemia genes increase risk for squamous lung cancer, 25
Wang (2010)
e164Nucleic Acids Res., 38
Y.H. Liu, J. Xia, J. McKay, S. Tsavachidis, X.J. Xiao, M.R. Spitz, C. Cheng, J. Byun, W. Hong, Y.F. Li (2021)
Rare deleterious germline variants and risk of lung cancer, 5
Islami (2018)
31CA Cancer J. Clin., 68
Aynaud (2012)
39182J. Biol. Chem., 287
Although multiple common susceptibility loci for lung cancer (LC) have been identified by genome-wide association studies, they can explain only a small portion of heritability. The etiological contribution of rare deleterious variants (RDVs) to LC risk is not fully characterized and may account for part of the missing heritability. Here, we sequenced the whole exomes of 2777 participants from the Environment and Genetics in Lung cancer Etiology study, a homogenous population including 1461 LC cases and 1316 controls. In single-variant analyses, we identified a new RDV, rs77187983 [EHBP1, odds ratio (OR) = 3.13, 95% confidence interval (CI) = 1.34–7.30, P = 0.008] and replicated two previously reported RDVs, rs11571833 (BRCA2, OR = 2.18; 95% CI = 1.25–3.81, P = 0.006) and rs752672077 (MPZL2, OR = 3.70, 95% CI = 1.04–13.15, P = 0.044). In gene-based analyses, we confirmed BRCA2 (P = 0.007) and ATM (P = 0.014) associations with LC risk and identified TRIB3 (P = 0.009), involved in maintaining genome stability and DNA repair, as a new candidate susceptibility gene. Furthermore, cases were enriched with RDVs in homologous recombination repair [carrier frequency (CF) = 22.9% versus 19.5%, P = 0.017] and Fanconi anemia (CF = 12.5% versus 10.2%, P = 0.036) pathways. Our results were not significant after multiple testing corrections but were enriched in cases versus controls from large scale public biobank resources, including The Cancer Genome Atlas, FinnGen and UK Biobank. Our study identifies novel candidate genes and highlights the importance of RDVs in DNA repair-related genes for LC susceptibility. These findings improve our understanding of LC heritability and may contribute to the development of risk stratification and prevention strategies.
Human Molecular Genetics – Oxford University Press
Published: Jun 18, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.